First Wave of Alexion Employees Move into New Global Headquarters in New Haven

Alexion’s first wave of employees have relocated to its new global headquarters at a state-of-the-art facility in New Haven, Connecticut. As Alexion works to fulfill its mission to transform the lives of patients with severe and devastating rare disorders, the move to New Haven enables the Company to keep pace with the rapid growth of the company’s global operations and expanding pipeline initiatives. The move will take place in phases, with approximately 1,000 employees moving into the new headquarters by the end of March.

As a company founded in New Haven 24 years ago, Alexion is pleased to continue growing in the state of Connecticut, to support the state’s economy through job creation, and to help drive Connecticut’s vision of becoming a leader in biopharmaceuticals. Alexion is excited to be in New Haven, a city which offers a central location for recruiting talent, has a knowledge-based economy, easy access to Amtrak and other mass transit systems, and offers a vibrant community for Alexion employees.